Drug Approval | October 02, 2024
Aurobindo Pharma receives USFDA approval for Cephalexin Tablets
The product is expected to be launched in Q3FY25
The product is expected to be launched in Q3FY25
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
Valbenazine Capsules had annual sales of US $1,993.6 mn in the United States (IQVIA MAT June 2024)
The product is bioequivalent and therapeutically equivalent to the reference listed drug
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
A significant proportion of healthcare professionals still tend to favor branded drugs
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
Distributes Ayushman cards to several beneficiaries
Subscribe To Our Newsletter & Stay Updated
